Latest NewsFDA NewsAdverse Event ManagementSupportive CareDisparities in Cancer CareDrug SafetyRadiation OncologySurvivorship Practice ManagementPreventionContributorsSponsored
Expert ConnectionsMorning RoundsThe VitalsPodcastsVideosBetween the LinesFrom All AnglesMeeting of the MindsTraining Academy
Conference CoverageConference Listing
Publications
Continuing Education
Case-Based Digest Rx Road MapWebinarsCancer Summary SlidesMPN Symptom ManagementEvents
SubscribePartners
Brain Cancer
Breast CancerBreast Cancer
Gastrointestinal CancerGastrointestinal CancerGastrointestinal CancerGastrointestinal Cancer
Genitourinary CancerGenitourinary CancerGenitourinary CancerGenitourinary Cancer
Gynecologic CancersGynecologic CancersGynecologic CancersGynecologic Cancers
Head and Neck Cancers
HematologyHematologyHematologyHematologyHematologyHematology
Lung Cancer
Pediatric Cancer
Sarcomas
Skin CancerSkin Cancer
Advanced Practice Corner Logo
    Brain Cancer
    Breast CancerBreast Cancer
    Gastrointestinal CancerGastrointestinal CancerGastrointestinal CancerGastrointestinal Cancer
    Genitourinary CancerGenitourinary CancerGenitourinary CancerGenitourinary Cancer
    Gynecologic CancersGynecologic CancersGynecologic CancersGynecologic Cancers
    Head and Neck Cancers
    HematologyHematologyHematologyHematologyHematologyHematology
    Lung Cancer
    Pediatric Cancer
    Sarcomas
    Skin CancerSkin Cancer
    Advanced Practice Corner Logo
        • Publications
        • Subscribe
        • Partners
      Advertisement

      Advanced Practice Providers


      Nurse Practitioners Speak Out Against 'Outdated' Practice Models

      Nurse Practitioners Speak Out Against 'Outdated' Practice Models

      Brielle Benyon
      December 16th 2020

      Oncology nurse practitioners are both competent and compassionate, and undergo rigorous academic and clinical training to earn the NP next to their name. However, many states still require them to work under the supervision of a physician.


      NP Explains Durvalumab' Benefit in NSCLC

      NP Explains Durvalumab' Benefit in NSCLC

      Brielle Benyon
      November 14th 2020

      Durvalumab showed a promising survival boost in stage III non-small cell lung cancer, and the immunotherapy agent was not as toxic as some thought it would be.


      NP Offers Insights on CRC Updates, Treatment Options

      NP Offers Insights on CRC Updates, Treatment Options

      Brielle Benyon
      November 11th 2020

      A nurse practitioner discusses mutations, cancer sidedness, and treatment duration for patients with colorectal cancer.


      Opioid Overview: Know What to Use and When

      Opioid Overview: Know What to Use and When

      Brielle Benyon
      September 24th 2020

      Pain management is both an art and a science, according to Jeannine Brant, PhD, APRN, AOCN, FAAN


      Blood cells

      3-Drug Carfilzomib Regimen Not Superior Than Standard of Care in Myeloma

      Jessica Skarzynski
      May 30th 2020

      Carfilzomib, lenalidomide, and dexamethasone did not demonstrate superior progression-free survival in newly diagnosed multiple myeloma.

      <1
      ...
      45678

      Latest Conference Coverage

      No Survival, Recurrence Benefit With Aspirin in CRC Liver Metastases

      Relacorilant Combo Sustains Ovarian Cancer Benefit Post Platinum Break

      Genomic Changes May Drive Sotorasib KRAS G12C+ Combo Resistance in CRC

      Relacorilant/Nab-Paclitaxel Is Convenient, Safe in Ovarian Cancer

      View More Latest Conference Coverage
      About Us
      Editorial Board
      Contact Us
      CancerNetwork.com
      CureToday.com
      OncLive.com
      TargetedOnc.com
      Advertise
      Privacy
      Terms & Conditions
      Do Not Sell My Information
      Contact Info

      2 Commerce Drive
      Cranbury, NJ 08512

      609-716-7777

      © 2025 MJH Life Sciences

      All rights reserved.